Home > Healthcare > Medical Devices > Therapeutic Devices > U.S. Intrauterine Devices Market
U.S. Intrauterine Devices Market Analysis
- Report ID: GMI2895
- Published Date: Mar 2023
- Report Format: PDF
U.S. Intrauterine Devices Market Analysis
On the basis of product, the U.S. intrauterine devices market from the hormonal IUD segment is expected to show a growth rate of more than 10% through 2032. Hormonal IUDs are suitable for people who cannot use estrogen and also help with painful menstrual cycles. They have shown 99% efficacy in pregnancy prevention, making them that much more preferred among women. In addition, they offer non-contraceptive benefits, are safe, and people suffering from endometriosis, fibroids, anemia, and menstrual flow can use them.
Based on age group, the U.S. intrauterine devices market from the 30-34 segment is anticipated to record a valuation of over USD 867.5 million by 2032, on account of growing abortion rates and unwanted pregnancies among women of this age group. The segment expansion can also be credited to surging awareness about different IUDs and their uses among females in the U.S.
Based on zone, the South Atlantic segment accounted for over 20% of the U.S. intrauterine devices market revenue share in 2022, driven by growing government and non-government initiatives towards family planning. Efforts towards expanding access to IUDs for preventing unintended pregnancies and abortions are creating a high impetus for market development. In fact, in states such as Florida, family planning and the associated preventive health services are available to both male and female populations in all 67 counties through the contracted agencies and local county health units.
Frequently Asked Questions (FAQ) :
U.S. Intrauterine Devices Market Scope
